Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1985 1
1988 2
1989 4
1990 6
1992 3
1994 1
1995 7
1996 6
1997 2
1998 1
1999 3
2000 6
2001 8
2002 4
2003 9
2004 5
2005 8
2006 22
2007 15
2008 9
2009 11
2010 13
2011 10
2012 10
2013 6
2014 8
2015 9
2016 16
2017 12
2018 7
2019 18
2020 22
2021 16
2022 10
2023 9
2024 13
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

274 results

Results by year

Filters applied: . Clear all
Page 1
Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer.
Heymach JV, Harpole D, Mitsudomi T, Taube JM, Galffy G, Hochmair M, Winder T, Zukov R, Garbaos G, Gao S, Kuroda H, Ostoros G, Tran TV, You J, Lee KY, Antonuzzo L, Papai-Szekely Z, Akamatsu H, Biswas B, Spira A, Crawford J, Le HT, Aperghis M, Doherty GJ, Mann H, Fouad TM, Reck M; AEGEAN Investigators. Heymach JV, et al. Among authors: harpole d. N Engl J Med. 2023 Nov 2;389(18):1672-1684. doi: 10.1056/NEJMoa2304875. Epub 2023 Oct 23. N Engl J Med. 2023. PMID: 37870974 Clinical Trial.
A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo.
Saunders LR, Bankovich AJ, Anderson WC, Aujay MA, Bheddah S, Black K, Desai R, Escarpe PA, Hampl J, Laysang A, Liu D, Lopez-Molina J, Milton M, Park A, Pysz MA, Shao H, Slingerland B, Torgov M, Williams SA, Foord O, Howard P, Jassem J, Badzio A, Czapiewski P, Harpole DH, Dowlati A, Massion PP, Travis WD, Pietanza MC, Poirier JT, Rudin CM, Stull RA, Dylla SJ. Saunders LR, et al. Among authors: harpole dh. Sci Transl Med. 2015 Aug 26;7(302):302ra136. doi: 10.1126/scitranslmed.aac9459. Sci Transl Med. 2015. PMID: 26311731 Free PMC article.
Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer.
Spicer JD, Cascone T, Wynes MW, Ahn MJ, Dacic S, Felip E, Forde PM, Higgins KA, Kris MG, Mitsudomi T, Provencio M, Senan S, Solomon BJ, Tsao MS, Tsuboi M, Wakelee HA, Wu YL, Chih-Hsin Yang J, Zhou C, Harpole DH, Kelly KL. Spicer JD, et al. Among authors: harpole dh. J Thorac Oncol. 2024 Oct;19(10):1373-1414. doi: 10.1016/j.jtho.2024.06.010. Epub 2024 Jun 18. J Thorac Oncol. 2024. PMID: 38901648
Design and Rationale for a Phase III, Double-Blind, Placebo-Controlled Study of Neoadjuvant Durvalumab + Chemotherapy Followed by Adjuvant Durvalumab for the Treatment of Patients With Resectable Stages II and III non-small-cell Lung Cancer: The AEGEAN Trial.
Heymach JV, Mitsudomi T, Harpole D, Aperghis M, Jones S, Mann H, Fouad TM, Reck M. Heymach JV, et al. Among authors: harpole d. Clin Lung Cancer. 2022 May;23(3):e247-e251. doi: 10.1016/j.cllc.2021.09.010. Epub 2021 Oct 10. Clin Lung Cancer. 2022. PMID: 34819266 Free article. Clinical Trial.
The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer.
Dunne EG, Fick CN, Isbell JM, Chaft JE, Altorki N, Park BJ, Spicer J, Forde PM, Gomez D, Iyengar P, Harpole DH Jr, Stinchcombe TE, Liberman M, Bott MJ, Adusumilli PS, Huang J, Rocco G, Jones DR. Dunne EG, et al. Among authors: harpole dh jr. Ann Thorac Surg. 2024 Jul;118(1):119-129. doi: 10.1016/j.athoracsur.2024.01.024. Epub 2024 Feb 3. Ann Thorac Surg. 2024. PMID: 38316378 Free PMC article. Review.
Reply to D.A. Palma.
Yang CJ, Chan DY, D'Amico TA, Berry MF, Harpole DH. Yang CJ, et al. Among authors: harpole dh. J Clin Oncol. 2017 Feb 10;35(5):572. doi: 10.1200/JCO.2016.70.2787. Epub 2016 Nov 21. J Clin Oncol. 2017. PMID: 27870575 No abstract available.
Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, Gillenwater HH, Watson DM, Sugarbaker DJ, Schilsky RL, Vokes EE, Green MR. Strauss GM, et al. Among authors: harpole dh. J Clin Oncol. 2008 Nov 1;26(31):5043-51. doi: 10.1200/JCO.2008.16.4855. Epub 2008 Sep 22. J Clin Oncol. 2008. PMID: 18809614 Free PMC article. Clinical Trial.
Discussion.
Rice D, Sugarbaker D, Flores R, Harpole D, Rusch V. Rice D, et al. Among authors: harpole d. J Thorac Cardiovasc Surg. 2016 Feb;151(2):473-5. doi: 10.1016/j.jtcvs.2015.09.133. Epub 2015 Nov 21. J Thorac Cardiovasc Surg. 2016. PMID: 26614415 Free article. No abstract available.
Going to MARS may shorten our patient's survival.
Ripley RT, Adusumilli PS, Bograd AJ, Bölükbas S, Bueno R, Cameron RB, de Perrot M, Flores RM, Groth SG, Lang-Lazdunski L, Harpole DH, Pass HI, Patel M, Schmitt-Opitz I, Ugalde Figueroa PA, Wolf AS. Ripley RT, et al. Among authors: harpole dh. J Thorac Cardiovasc Surg. 2025 Jun;169(6):1597-1603. doi: 10.1016/j.jtcvs.2024.12.006. Epub 2024 Dec 13. J Thorac Cardiovasc Surg. 2025. PMID: 39675416 No abstract available.
274 results